If you take Zantac or a generic version to control your heartburn, you'll need to find an alternative.

Yesterday, the FDA announced they would be calling for an immediate market withdrawal of prescription and over the counter ranitidine.




 

After months of investigation, the FDA determined the heartburn medication to contain trace amounts of a carcinogen called N-Nitrosodimethylamine (NDMA).

The World Health Organization (WHO) has listed N-Nitrosodimethylamine as a "probable human carcinogen."

According to the FDA's news release, they have "determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures."

The FDA advisory said people already taking Zantac should stop and switch to other heartburn medications, and to be sure the new medication doesn't contain ranitidine.

Read More at NBC News

Enter your number to get our free mobile app